Unknown

Dataset Information

0

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.


ABSTRACT: AIMS: Persistent infection indicated by detection of human papillomavirus 16 (HPV-16) on repeat testing over a period of time poses the greatest cervical cancer risk. However, variants of HPV-16, HPV-31 and HPV-33 may share several short sequence homologies in the hypervariable L1 gene commonly targeted for HPV genotyping. The purpose of this study was to introduce a robust laboratory procedure to validate HPV-16 detected in clinical specimens, using the GenBank sequence database as the standard reference for genotyping. METHODS: A nested PCR with two pairs of consensus primers was used to amplify the HPV DNA released in crude proteinase K digest of the cervicovaginal cells in liquid-based Papanicolaou cytology specimens. The positive nested PCR products were used for direct automated DNA sequencing. RESULTS: A 48-base sequence downstream of the GP5+ priming site, or a 34-base sequence upstream thereof, was needed for unequivocal validation of an HPV-16 isolate. Selection of a 45-base, or shorter, sequence immediately downstream of the GP5+ site for Basic Local Alignment Search Tool sequence analysis invariably led to ambiguous genotyping results. CONCLUSIONS: DNA sequence analysis may be used for differential genotyping of HPV-16, HPV-31 and HPV-33 in clinical specimens. However, selection of the signature sequence for Basic Local Alignment Search Tool algorithms is crucial to distinguish certain HPV-16 variants from other closely related HPV genotypes.

SUBMITTER: Lee SH 

PROVIDER: S-EPMC2921263 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.

Lee Sin Hang SH   Vigliotti Veronica S VS   Pappu Suri S  

Journal of clinical pathology 20091026 3


<h4>Aims</h4>Persistent infection indicated by detection of human papillomavirus 16 (HPV-16) on repeat testing over a period of time poses the greatest cervical cancer risk. However, variants of HPV-16, HPV-31 and HPV-33 may share several short sequence homologies in the hypervariable L1 gene commonly targeted for HPV genotyping. The purpose of this study was to introduce a robust laboratory procedure to validate HPV-16 detected in clinical specimens, using the GenBank sequence database as the s  ...[more]

Similar Datasets

| S-EPMC9587812 | biostudies-literature
| S-EPMC3827439 | biostudies-literature
| S-EPMC165259 | biostudies-literature
| S-EPMC2691405 | biostudies-literature
| S-EPMC3466057 | biostudies-literature
| S-EPMC5543637 | biostudies-literature
| S-EPMC4424305 | biostudies-literature
| S-EPMC1234115 | biostudies-literature
| S-EPMC7059378 | biostudies-literature
| S-EPMC2708609 | biostudies-literature